Professor Sung Wan Kim passed away peacefully, surrounded by family and friends on February 24, 2020 at the University of Utah Medical Center. He was born on August 21, 1940 in Busan, South Korea. Prof. Kim was a distinguished professor in Pharmaceutics and Pharmaceutical Chemistry and also in Bioengineering at the University of Utah. Despite being surrounded by poverty and the difficulties of the Korean War, he followed the advice of his mother to seek a career in chemistry and enrolled at Seoul National University where he received his B.S. in chemistry and M.S. in physical chemistry in 1963 and 1965, respectively. In 1966, he left South Korea to pursue his dreams and embarked on research at the University of Utah under Prof. Henry Eyring. After Prof. Kim received his Ph.D. in 1969, Prof. Eyring introduced him to Prof. Willem Johan Kolff, who guided him in the direction of the groundbreaking fields of biomaterials, medicinal devices, and artificial organs. Since 1969, Prof. Kim has published more than 830 papers and holds 38 patents in those fields that Profs. Eyring and Kolff led him into. He was also elected to be a member of the National Academy of Medicine in 1999 and the National Academy of Engineering in 2003. He has received numerous awards including the Clemson Award from The Society for Biomaterials, the Founders Award from CRS, the Research Achievement Award-Pharmaceutical Sciences World Conference, The University of Utah\'s Rosenblatt Prize for Excellence, and the American Association of Pharmaceutical Scientists (AAPS) Dale Wurster Award. As founder of three biotech companies, Prof. Kim was proud of the work he did to develop technologies that would ultimately improve the lives of people across the globe.

Prof. Kim is known as a pioneer in the world of pharmaceutics. From 1971, his research was firstly focused on the mechanism of surface-induced thrombosis and the prevention of thrombus formation on polymer surfaces. Then, from 1976, Prof. Kim started to develop biodegradable polymer-drug conjugates. From 1982, he also designed stimuli sensitive hydrogels and stimuli-responsive drug delivery. Based on these research backgrounds, he proposed new a therapeutic concept of "self-regulated drug delivery", such as glucose-responding insulin release using his own designed bio-hydrogels. From 1996, he provided his unique biomedical applications of concept and technology for cell and gene delivery. Prof. Kim recognized scientific needs faster than anyone, and successfully provided scientific direction. His scientific concepts have influenced many researchers. Prof. Kim was a pioneer and world leader in biomedical polymers and their pharmaceutical applications.

In Addition, Prof. Kim was a highly esteemed scientist as well as a passionate mentor. Since 1974, Prof. Kim has trained more than 150 students and postdocs, and he has been a pillar in the College of Pharmacy at the University of Utah. Prof. Kim influenced countless people as an advisor. His incredible energy and remarkable legacy will continue to inspire all who had the privilege to learn from him. A generous philanthropist, Prof. Kim supported various organizations including academic institutions and medical centers.

Prof. Kim was obligated to promote new fields of biomaterials and drug delivery. He focused on special efforts to initiate bio-ventures for unique pharmaceutical products to rescue many patients suffering from difficult and chronic diseases. Equipped with a long-term vision for the biomedical polymer and pharmaceutical field, he gave tremendous effort to support and inspire students and young researchers, not only in the US, but in the world.

From 1986, Profs. Sung Wan Kim, Jan Feijen, and Teruo Okano had initiated "Triangle research Collaboration" and promoted collaboration among the US, Netherlands, and Japan. Many students traveled to these different countries to promote original biomaterials and drug delivery research. More than 50 professors were generated from this program and have educated subsequent generations of students and researchers. The triangle research collaboration system supported and encouraged the initiation of new research fields for biomaterials and drug delivery in Korea, which generated excellent leaders. Prof. Kim always considered the future and imagined the new technology breakthroughs that could propel these fields. He never hesitated to travel to educate and to inspire researchers across the world. I believe Prof. Kim\'s passion for innovation in biomaterials and drug delivery is carried on by many researchers in the world.
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